Citizens Financial Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-25,822
Closed -$1.67M – 1062
2026
Q1
$1.67M Buy
+25,822
New +$1.82M 0.02% 303
2020
Q3
– Sell
-278
Closed -$7K – 523
2020
Q2
$7K Buy
+278
New +$6.27K ﹤0.01% 830

Other funds holding HALO

Citizens Financial Group's HALO Position: Q2 2026 in Review

Citizens Financial Group sold out of Halozyme (HALO) in Q2 2026, closing a stake of 25,822 shares — an estimated $1.67M sold.

Citizens Financial Group first reported a position in HALO in Q2 2020 and held it in 2 quarters. The position peaked at $1.67M in Q1 2026. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Citizens Financial Group reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Citizens Financial Group sold 25,822 Halozyme shares in Q2 2026, an estimated $1.67M.
  • Citizens Financial Group first reported a position in Halozyme in Q2 2020 and held it in 2 quarters.
  • Citizens Financial Group's Halozyme position peaked at $1.67M in Q1 2026.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.